arrow
A

Anna Skiada

National and Kapodistrian University of Athens
H指数:38
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Invasive and Severe Localized Infections Caused by Fusarium Species and Other Rare Filamentous Fungi in Greece: A Prospective Epidemiological Study

由镰刀菌属和其他罕见丝状真菌引起的侵袭性和严重局部感染:希腊一项前瞻性流行病学研究

2026-01-010
OA
Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial

碳青霉烯耐药肠杆菌科细菌(CRE)在黏菌素单药治疗和黏菌素-美罗培南联合治疗后的获得及分子特征:AIDA随机试验结果

2025-11-060
OAAI
Virulence factors are preserved within carbapenem-resistant Acinetobacter baumannii clades

毒力因子在碳青霉烯耐药的鲍曼不动杆菌谱系中得以保留

2025-08-240
OAAI
A Global Analysis of Cases of Mucormycosis Recorded in the European Confederation of Medical Mycology / International Society for Human and Animal Mycology (ECMM / ISHAM) Zygomyco.net Registry from 2009 to 2022

2009年至2022年间记录在欧洲医学真菌学会/国际人类与动物真菌学会(ECMM / ISHAM)Zygomyco.net登记系统中的毛霉菌病病例的全球分析

2025-06-100
PRE
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii

耐碳青霉烯类鲍曼不动杆菌中粘菌素异源耐药的患病率和临床后果以及完全耐药的演变

2023-06-1517
OAAI
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria
2020-12-0122
OAAI
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
2020-09-0158
OAAI
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

毛霉菌病诊断和管理的全球指南: 欧洲医学真菌学联合会与真菌病研究小组教育和研究联合会合作的一项倡议

2019-12-011.1K
OAAI
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms

在耐碳青霉烯类细菌引起的感染患者中,多粘菌素-美罗培南联合治疗与多粘菌素单药治疗后的多粘菌素耐药性发展

2019-11-2311
PREAI
Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility
2019-06-0126
OA
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

曲霉菌病的诊断和管理: 2017 escmid-ecmm-ers指南的执行摘要

2018-05-01862
OAAI
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

多粘菌素单用与多粘菌素联合美罗培南治疗耐碳青霉烯类革兰氏阴性菌引起的严重感染: 一项开放标签、随机对照试验

2018-04-01441
PREAI
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
2014-04-01382
OA
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
2014-04-01508
OA
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

ESCMID和ECMM联合诊断和管理系统性pha菌丝性真菌病的临床指南: 黑色真菌引起的疾病

2014-04-01257
OA